{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T06:57:44Z","timestamp":1774853864856,"version":"3.50.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute for Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 DK110539"],"award-info":[{"award-number":["K23 DK110539"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteogenesis imperfecta (OI) encompasses a genetically diverse spectrum of skeletal dysplasias, commonly linked to pathogenic variants in COL1A1 and COL1A2. Emerging data identify terminal nucleotidyltransferase 5A (TENT5A)\u2014a noncanonical cytoplasmic poly(A) polymerase essential for mRNA stability of extracellular matrix (ECM) proteins\u2014as a novel OI gene. However, human phenotypes associated with TENT5A impairment and its molecular underpinnings remain poorly characterized. We performed detailed clinical, biochemical, and transcriptomic characterization of a Palestinian male with homozygous TENT5A variant (NM_001370434: c.972C&amp;gt;G, p. Ile324Met). Functional studies were conducted on patient-derived fibroblasts subjected to osteogenic induction, assessing matrix mineralization, mRNA expression, poly(A) tail dynamics (via Nanopore direct RNA sequencing), and stress response. RNA-seq and qPCR were used to profile osteogenic and epigenetic gene expression. Despite normal stature and preserved long bone architecture, the proband exhibited recurrent small bone fractures and persistently elevated alkaline phosphatase. Fibroblasts from the proband demonstrated reduced mineralization and significantly shortened poly(A) tails in COL1A1 and COL1A2 transcripts, corresponding to decreased expression. Transcriptomic analysis revealed downregulation of key ECM, osteogenic, and chromatin-regulatory genes, alongside increased ribosomal transcripts and translational machinery. Poly(A) tail shortening was selective, affecting ECM and regulatory genes but sparing housekeeping genes. Under metabolic stress, TENT5A-impaired fibroblasts showed markedly reduced viability, indicating broader cellular vulnerability. Despite these molecular disruptions, clinical severity remained mild, possibly modulated by early bisphosphonate therapy. This case defines a distinct form of OI arising from post-transcriptional dysregulation in matrix-producing cells. TENT5A alteration compromises ECM production by destabilizing collagen mRNAs, disrupting osteogenic and epigenetic programs, and impairing cellular resilience. Our findings identify a novel homozygous TENT5A variant and demonstrate its pathogenic effect on osteoblast function and matrix mineralization, supporting the inclusion of TENT5A in diagnostic panels for unexplained skeletal fragility.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziag029","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:57:54Z","timestamp":1771505874000},"source":"Crossref","is-referenced-by-count":0,"title":["Impaired bone matrix turnover with selective small bone fragility in a child with\n                    <i>TENT5A<\/i>\n                    -associated osteogenesis imperfecta"],"prefix":"10.1093","volume":"10","author":[{"given":"Alex","family":"Guo","sequence":"first","affiliation":[{"name":"Division of Molecular Genetics, Department of Pediatrics, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Tillotson","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Virginia Tech Carilion School of Medicine , Roanoke, VA 24015 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Sena","sequence":"additional","affiliation":[{"name":"Division of Molecular Genetics, Department of Pediatrics, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adhirai","family":"Muthukumar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhulatha","family":"Pantrangi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mythily","family":"Ganapathi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Gewartowska","sequence":"additional","affiliation":[{"name":"Genome Engineering Facility, International Institute of Molecular and Cell Biology in Warsaw , Warsaw , 02-109","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142 S","family":"Krawczyk","sequence":"additional","affiliation":[{"name":"Laboratory of RNA Biology, International Institute of Molecular and Cell Biology in Warsaw , Warsaw , 02-109","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhu V","family":"Thaker","sequence":"additional","affiliation":[{"name":"Division of Molecular Genetics, Department of Pediatrics, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]},{"name":"Division of Pediatric Endocrinology, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]},{"name":"Vagelos College of Physicians and Surgeons, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6590-1555","authenticated-orcid":false,"given":"Ekaterina","family":"Semenova","sequence":"additional","affiliation":[{"name":"Division of Molecular Genetics, Department of Pediatrics, Columbia University Medical Center , New York, NY 10032 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"1","key":"2026033001315997600_ref1","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-017-0115-5","article-title":"Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients","volume":"11","author":"Zhytnik","year":"2017","journal-title":"Human Genom"},{"issue":"7","key":"2026033001315997600_ref2","doi-asserted-by":"crossref","DOI":"10.1038\/s41431-019-0373-x","article-title":"Genotype\u2013phenotype correlation study in 364 osteogenesis imperfecta Italian patients","volume":"27","author":"Maioli","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"2026033001315997600_ref3","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-024-01266-5","article-title":"Update on the genetics of osteogenesis imperfecta","volume":"115","author":"Jovanovic","year":"2024","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2026033001315997600_ref4","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-291X(02)00228-0","article-title":"Identification and characterization of C6orf37, a novel candidate human retinal disease gene on chromosome 6q14","volume":"293","author":"Lagali","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"3-4","key":"2026033001315997600_ref5","doi-asserted-by":"crossref","DOI":"10.1007\/s00335-016-9619-x","article-title":"Exome sequencing identifies a nonsense mutation in Fam46a associated with bone abnormalities in a new mouse model for skeletal dysplasia","volume":"27","author":"Diener","year":"2016","journal-title":"Mamm Genome"},{"issue":"4","key":"2026033001315997600_ref6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jmedgenet-2017-104999","article-title":"FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta","volume":"55","author":"Doyard","year":"2018","journal-title":"J Med Genet"},{"issue":"21","key":"2026033001315997600_ref7","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1101\/gad.11.21.2755","article-title":"Mechanism and regulation of mRNA polyadenylation","volume":"11","author":"Colgan","year":"1997","journal-title":"Genes Dev"},{"issue":"4","key":"2026033001315997600_ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm2370","article-title":"Multifunctional deadenylase complexes diversify mRNA control","volume":"9","author":"Goldstrohm","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2026033001315997600_ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109015","article-title":"Cytoplasmic polyadenylation by TENT5A is required for proper bone formation","volume":"35","author":"Gewartowska","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"2026033001315997600_ref10","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1038\/s41598-022-13026-2","article-title":"Clinical exome sequencing for inherited retinal degenerations at a tertiary care center","volume":"12","author":"Ganapathi","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"2026033001315997600_ref11","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"issue":"5","key":"2026033001315997600_ref12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"2026033001315997600_ref13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","article-title":"Bone turnover markers in patients with osteogenesis imperfecta","volume":"34","author":"Braga","year":"2004","journal-title":"Bone"},{"issue":"2","key":"2026033001315997600_ref14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S002966510800699X","article-title":"Biomarkers of bone health and osteoporosis risk","volume":"67","author":"Eastell","year":"2008","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"2026033001315997600_ref15","first-page":"97","article-title":"Biochemical markers of bone turnover: part I: biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin Biochem Rev"},{"issue":"9","key":"2026033001315997600_ref16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41580-020-0246-8","article-title":"A tale of non-canonical tails: gene regulation by post-transcriptional RNA tailing","volume":"21","author":"Yu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2026033001315997600_ref17","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bbadis.2019.04.018","article-title":"COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing","volume":"1865","author":"Barnes","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"2026033001315997600_ref18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1242\/dev.02308","article-title":"Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis","volume":"133","author":"Le Goff","year":"2006","journal-title":"Development"},{"key":"2026033001315997600_ref19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4419-1050-9_5","article-title":"Regulation of osteoblast differentiation by Runx2","volume":"658","author":"Komori","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"2026033001315997600_ref20","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/jbmr.4386","article-title":"Runt-related transcription factor-2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice","volume":"36","author":"Qin","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026033001315997600_ref21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15476286.2023.2275109","article-title":"Regulation and function of alternative polyadenylation in development and differentiation","volume":"20","author":"Gallicchio","year":"2023","journal-title":"RNA Biol"},{"key":"2026033001315997600_ref22","doi-asserted-by":"crossref","first-page":"816398","DOI":"10.3389\/fmolb.2021.816398","article-title":"Functions and regulation of translation elongation factors","volume":"8","author":"Xu","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2026033001315997600_ref23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010817","article-title":"LncRNA WDR11-AS1 promotes extracellular matrix synthesis in osteoarthritis by directly interacting with RNA-binding protein PABPC1 to stabilize SOX9 expression","volume":"24","author":"Huang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026033001315997600_ref24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","article-title":"Bone remodeling: an operational process ensuring survival and bone mechanical competence","volume":"10","author":"Bolamperti","year":"2022","journal-title":"Bone Res"},{"issue":"12","key":"2026033001315997600_ref25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122045","article-title":"Cell death in chondrocytes, osteoblasts, and osteocytes","volume":"17","author":"Komori","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026033001315997600_ref26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1359\/jbmr.2000.15.1.60","article-title":"Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo","volume":"15","author":"Verborgt","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026033001315997600_ref27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"issue":"24","key":"2026033001315997600_ref28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2026033001315997600_ref29","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/HYPERTENSIONAHA.117.09045","article-title":"Tissue inhibitor of matrix metalloproteinase-1 promotes myocardial fibrosis by mediating CD63-integrin \u03b21 interaction","volume":"69","author":"Takawale","year":"2017","journal-title":"Hypertension"},{"issue":"1-2","key":"2026033001315997600_ref30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11154-006-9000-6","article-title":"Bone morphogenetic proteins and their antagonists","volume":"7","author":"Gazzerro","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"issue":"50","key":"2026033001315997600_ref31","doi-asserted-by":"crossref","first-page":"18023","DOI":"10.1073\/pnas.0503617102","article-title":"BMP signaling stimulates cellular differentiation at multiple steps during cartilage development","volume":"102","author":"Kobayashi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026033001315997600_ref32","doi-asserted-by":"crossref","first-page":"117043","DOI":"10.1016\/j.bone.2024.117043","article-title":"Epigenetic regulators controlling osteogenic lineage commitment and bone formation","volume":"181","author":"Dashti","year":"2024","journal-title":"Bone"},{"issue":"3","key":"2026033001315997600_ref33","first-page":"698","article-title":"The role of DNA methylation in common skeletal disorders","volume":"1","author":"Delgado-Calle","year":"2012","journal-title":"Biology (Basel)"},{"key":"2026033001315997600_ref34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2015.03.013","article-title":"Multiple levels of epigenetic control for bone biology and pathology","volume":"81","author":"Montecino","year":"2015","journal-title":"Bone"},{"key":"2026033001315997600_ref35","doi-asserted-by":"crossref","first-page":"117085","DOI":"10.1016\/j.bone.2024.117085","article-title":"Skeletal abnormalities in mice with Dnmt3a missense mutations","volume":"183","author":"Bell-Hensley","year":"2024","journal-title":"Bone"},{"issue":"46","key":"2026033001315997600_ref36","doi-asserted-by":"crossref","first-page":"27604","DOI":"10.1074\/jbc.M115.672345","article-title":"Epigenetic control of skeletal development by the histone methyltransferase Ezh2","volume":"290","author":"Dudakovic","year":"2015","journal-title":"J Biol Chem"},{"issue":"7","key":"2026033001315997600_ref37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat Med"},{"issue":"6","key":"2026033001315997600_ref38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nm.3544","article-title":"Excessive transforming growth factor-beta signaling is a common mechanism in osteogenesis imperfecta","volume":"20","author":"Grafe","year":"2014","journal-title":"Nat Med"},{"key":"2026033001315997600_ref39","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1038\/boneres.2016.9","article-title":"TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease","volume":"4","author":"Wu","year":"2016","journal-title":"Bone Res"},{"issue":"10","key":"2026033001315997600_ref40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41576-019-0145-z","article-title":"Alternative cleavage and polyadenylation in health and disease","volume":"20","author":"Gruber","year":"2019","journal-title":"Nat Rev Genet"},{"key":"2026033001315997600_ref41","doi-asserted-by":"crossref","first-page":"102234","DOI":"10.1016\/j.arr.2024.102234","article-title":"The role and mechanism of RNA-binding proteins in bone metabolism and osteoporosis","volume":"96","author":"Wu","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2026033001315997600_ref42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11657-025-01515-6","article-title":"Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trials","volume":"20","author":"Wang","year":"2025","journal-title":"Arch Osteoporos"},{"issue":"1","key":"2026033001315997600_ref43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"15","key":"2026033001315997600_ref44","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"issue":"12","key":"2026033001315997600_ref45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41431-024-01645-4","article-title":"Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study","volume":"32","author":"Charpie","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"2026033001315997600_ref46","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1210\/clinem\/dgaa450","article-title":"Cardiovascular safety of abaloparatide in postmenopausal women with osteoporosis: analysis from the ACTIVE phase 3 trial","volume":"105","author":"Cosman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"2026033001315997600_ref47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"16","key":"2026033001315997600_ref48","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"2026033001315997600_ref49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"issue":"40","key":"2026033001315997600_ref50","doi-asserted-by":"crossref","first-page":"41998","DOI":"10.1074\/jbc.M403702200","article-title":"Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation","volume":"279","author":"Schroeder","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"2026033001315997600_ref51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2026033001315997600_ref52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fonc.2020.01387","article-title":"CRISPR gene therapy: applications, limitations, and implications for the future","volume":"10","author":"Uddin","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"2026033001315997600_ref53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","article-title":"Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta","volume":"86","author":"Christiansen","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2026033001315997600_ref54","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/humu.22139","article-title":"Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix","volume":"33","author":"Barnes","year":"2012","journal-title":"Hum Mutat"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziag029\/67068012\/ziag029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/4\/ziag029\/67068012\/ziag029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/4\/ziag029\/67068012\/ziag029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:32:13Z","timestamp":1774848733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziag029\/8494663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziag029","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,23]]},"article-number":"ziag029"}}